Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Ava Grace 2025 Nov 14, 00:00

Investor Alert: Is the US Stock Market Nearing a Turning Point?

Ava Grace 2025 Nov 14, 00:00

Can the AI Boom Sustain the US Economy? Navigating Deglobalization

Sophia Claire 2025 Nov 14, 00:00

Market Risk: Strong Economy Forces Fed to Be Hawkish

Ghko B 2025 Nov 13, 16:00

What will VOO ETF be in 2040: Is Vanguard S&P 500 ETF a good buy?

Ghko B 2025 Nov 13, 16:00

AI chip stock analysis: AMD stock surges, what’s driving AMD stock rally?

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Frances Wang 2025 Nov 11, 16:00

Stock market today: NASDAQ: NVDA slides, MSFT stock, AAPL jumps 2%

Frances Wang 2025 Nov 11, 16:00

XRP price prediction: Why Is XRP price rising today? Could XRP hit $10?

Latest news

Show more
Ava Grace 2025 Nov 14, 06:10

Continuous Clearing Auction: New Asset Price Discovery with Uniswap and Aztec

Noah Lee 2025 Nov 14, 06:00

FDIC Mulls Tokenized Deposit Insurance, Stablecoin Application Process

Ava Grace 2025 Nov 14, 05:50

Kraken CEO: No Rush for US IPO Despite Market Rebound and Crypto Enthusiasm

Liam James 2025 Nov 14, 05:10

Uniswap (UNI) Analysis: Fee Switch Proposal, Token Future, and Ecosystem Dynamics

Ava Grace 2025 Nov 14, 04:20

Warning: Malicious Ethereum Wallet Extension on Chrome Store Steals Seed Phrases

Sophia Claire 2025 Nov 14, 03:30

US Economy Faces Data Black Hole: Will Delayed Metrics Impede Fed Decisions?

Liam James 2025 Nov 14, 03:10

The Future of Hyperliquid Lies in HIP-3: An Analysis of HyperStone's Foundation

Ava Grace 2025 Nov 14, 03:10

Bitcoin Whale Selling: Late-Cycle Behavior or Market Top Signal?

Info

Spread

2.14

Spread (%)

0.6389 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

180929495040

Shares Outstanding

538480671

Earnings Date (Next)

1999-11-22

Div Yield

2025-12-12

Ex-Dividend Date

2025-11-21

Forward annual dividend rate

9.52

Forward annual dividend yield

0.0283

EPS

12.94

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 12, 16:00

WTI crude oil price today: WTI crude oil target, trade oil with markets.com

Ghko B 2025 Nov 11, 16:00

Crude oil trading: commodity trading, best way to invest in WTI/Brent oil?

Ghko B 2025 Nov 11, 16:00

WTI trades at $60.75: WTI oil up 1.7%, What influences WTI oil prices?

Trustpilot